Bio-Rad Laboratories, Inc.Class A (BIO) is a publicly traded Healthcare sector company. As of November 4, 2026, BIO trades at $375.37 with a market cap of $9.79B and a P/E ratio of 46.18. BIO moved +0.12% today. Year to date, BIO is +22.78%; over the trailing twelve months it is +20.35%. Its 52-week range spans $211.43 to $396.23. Analyst consensus is buy with an average price target of $360.00. Rallies surfaces BIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Bio-Rad Laboratories, Inc.Class A (BIO) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. BIO moved +0.12% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $375.37 |
| Market Cap | $9.79B |
| P/E Ratio | 46.18 |
| EPS | $8.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $396.23 |
| 52-Week Low | $211.43 |
| Volume | 4 |
| Avg Volume | 0 |
| Revenue (TTM) | $2.59B |
| Net Income | $222.40M |
| Gross Margin | 51.90% |
2 analysts cover BIO: 0 strong buy, 1 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $360.00.